Kiora Pharmaceuticals (KPRX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts KPRX Hot Sheet
Join SI Premium – FREE
Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 EPS of $0.01.
For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PowerShares QQQ Trust (QQQ) call put ratio 1 call to 1.5 puts as share price near all-time high
- Sphere Entertainment (SPHR) PT Lowered to $160 at BTIG
- Wells Fargo Upgrades Cleveland-Cliffs (CLF) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
